Moomoo AI 已提取核心訊息
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. The program is part of a larger 12-month initiative to buy back shares worth up to DKK 20 billion, which started on the same date in 2023. As of February 19, 2024, the company has repurchased 394,500 B shares at an average price of DKK 830.60, totaling DKK 327,673,060. This buyback is in line with the Safe Harbour Rules of the European Union. Novo Nordisk, which has a strong heritage in diabetes care, is committed to defeating serious chronic diseases and employs approximately 63,400 people worldwide. The company's B shares are traded on Nasdaq Copenhagen, and its ADRs are listed on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. The program is part of a larger 12-month initiative to buy back shares worth up to DKK 20 billion, which started on the same date in 2023. As of February 19, 2024, the company has repurchased 394,500 B shares at an average price of DKK 830.60, totaling DKK 327,673,060. This buyback is in line with the Safe Harbour Rules of the European Union. Novo Nordisk, which has a strong heritage in diabetes care, is committed to defeating serious chronic diseases and employs approximately 63,400 people worldwide. The company's B shares are traded on Nasdaq Copenhagen, and its ADRs are listed on the New York Stock Exchange.
全球領先的醫療保健公司諾和諾德A/S宣佈繼續其股票回購計劃，該計劃於2024年2月6日開始。該計劃是2023年同日啓動的爲期12個月的更大規模計劃的一部分，該計劃旨在回購價值高達200億丹麥克朗的股票。截至2024年2月19日，該公司已回購了394,500股B股，平均價格爲830.60丹麥克朗，總額爲327,673,060丹麥克朗。此次回購符合歐盟的《安全港規則》。諾和諾德在糖尿病護理方面有着悠久的傳統，致力於戰勝嚴重的慢性病，在全球擁有約63,400名員工。該公司的B股在哥本哈根納斯達克上市，其ADR在紐約證券交易所上市。
全球領先的醫療保健公司諾和諾德A/S宣佈繼續其股票回購計劃，該計劃於2024年2月6日開始。該計劃是2023年同日啓動的爲期12個月的更大規模計劃的一部分，該計劃旨在回購價值高達200億丹麥克朗的股票。截至2024年2月19日，該公司已回購了394,500股B股，平均價格爲830.60丹麥克朗，總額爲327,673,060丹麥克朗。此次回購符合歐盟的《安全港規則》。諾和諾德在糖尿病護理方面有着悠久的傳統，致力於戰勝嚴重的慢性病，在全球擁有約63,400名員工。該公司的B股在哥本哈根納斯達克上市，其ADR在紐約證券交易所上市。
有用
沒用